EGFR-HER2 inhibitor EGF816, Purity ≥98%

Cat. No.: X24-05-ZQ647

EGFR-HER2 inhibitor EGF816, Purity ≥98%

Synonym: 1508250-71-2; EGF-816; EGF 816; Nazartinib; EGFR-HER2 inhibitor

  • CAS Number: 1508250-71-2
  • Compound CID: 72703790
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
EGF816, soluble in DMSO and ethanol and insoluble in water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR(L858R/T790M).
Molecular Weight
495.02
Molecular Formula
C26H31ClN6O2
Targets
EGFR(L858R/T790M): 31 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 92 mg/mL (185.85 mM); Water: Insoluble; Ethanol: 92 mg/mL (185.85 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
EGF816 is applied in research focusing on its selective inhibition of EGFR mutant forms in cancer therapies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.